OpenAI CEO Sam Altman's suggestion of slowing AI development is likely a strategic move. It could be a trial balloon to appease doomsayers and gauge public opinion, rather than a genuine commitment to cede their market lead.

Top AI labs like Anthropic publicly state that slowing down AI development would benefit society. However, they are caught in a strategic trap: a unilateral pause is unviable. Without a global agreement, any lab that pauses simply allows less cautious competitors to seize the lead, potentially making the ecosystem less safe.

Skeptics argue the call to 'pace' AI development is primarily a business strategy. They claim labs need to reduce massive model training costs and explain slowing growth to become viable for an IPO, making the slowdown a matter of economic necessity disguised as a safety concern.

The focus on AI risk overlooks the opportunity cost of "pacing." Delaying frontier model development, while potentially safer, also pushes back the timeline for major societal benefits like AI-driven scientific discoveries and disease cures, creating a difficult societal trade-off.

There is a fundamental contradiction when AI leaders publicly warn of existential risks while also aggressively fundraising and preparing for IPOs. If the danger were truly imminent, the logical action would be to halt development, not capitalize on it. This discrepancy suggests financial motives may outweigh safety concerns.

Handshake's CEO suggests that while AI safety is important, the constant focus on existential risks conveniently distracts from a more immediate problem: frontier models struggle to deliver tangible ROI in enterprise settings outside of software engineering, leading to high token costs without proportional productivity gains.

The AI market narrative is shifting. Previously, users boasted about using the most powerful models. Now, influential figures like Coinbase's CEO brag about cost-saving by using cheaper alternatives. This shift directly undermines the high-growth, high-margin story essential for the upcoming IPOs of companies like OpenAI and Anthropic.

The publicly cited reason for OpenAI delaying its IPO until 2027 is market volatility. However, the host speculates the true cause is unsustainable spending and slowing growth, forcing the company to undertake a significant cost-reduction effort before it can face public market scrutiny.

Calls to slow AI development aren't just regulatory capture. Didi Das notes that researchers at top labs are exposed to models far more advanced than the public sees, and many are "genuinely scared" by their capabilities, independent of financial incentives. This fear stems from direct, privileged access to future technology.